Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Eagle Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Eagle Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tarriff Scott | 10% Owner | 460,621 | Mar 1, 2024 | 0 |
| Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | 47,958 | Feb 29, 2024 | 0 |
| Graves Michael | Interim Executive Chair & PEO | 10,360 | Dec 22, 2023 | 0 |
| Ratoff Steven B | Director | – | Mar 9, 2023 | 0 |
| Simpson Jennifer K. | Director | – | Mar 9, 2023 | 0 |
| Glenning Robert | Director | – | Mar 9, 2023 | 0 |
| Edlin Richard A. | Director | 22,600 | Mar 9, 2023 | 0 |
| Borio Luciana | Director | – | Mar 9, 2023 | 0 |
| Moran Michael Shawn | EVP, Chief Commercial Officer | 32,115 | Mar 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 (view filing) | Nov 1-2 | 2 days | Tarriff ScottCEO | SSale | −21.6K | $13.84 | −$299.3K | −3.8%545.4K after | 2 lots10b5-1 |
| Oct 4, 2023 (view filing) | Oct 2-3 | 2 days | Tarriff ScottCEO | SSale | −20.2K | $14.82 | −$300.0K | −3.4%567.1K after | 3 lots10b5-1 |
| May 18, 2023 (view filing) | May 16 | 2 days | Tarriff ScottCEO | SSale | −15.0K | $19.98 | −$299.7K | −2.5%587.3K after | |
| May 15, 2023 (view filing) | May 11-15 | 4 days | Tarriff ScottCEO | SSale | −45.0K | $20.68 | −$930.7K | −2.7%1.59M after | 5 lots |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Edlin Richard A.Director | SSale | −6.80K | $30.99 | −$210.7K | −23.1%22.6K after |